HESTER BIOSCIENCES Financial Statement Analysis
|
||
|
The Revenues of HESTER BIOSCIENCES have increased by 14.45% YoY .
The Earnings Per Share (EPS) of HESTER BIOSCIENCES has decreased by -29.07 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
HESTER BIOSCIENCES Last 5 Annual Financial Results
[BOM: 524669|NSE : HESTERBIO]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹305 Cr | ₹266 Cr | ₹235 Cr | ₹214 Cr | ₹183 Cr |
| Expenses | ₹251 Cr | ₹216 Cr | ₹175 Cr | ₹146 Cr | ₹128 Cr |
| Operating Profit (Excl OI) | ₹53 Cr | ₹50 Cr | ₹60 Cr | ₹69 Cr | ₹55 Cr |
| Other Income | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹4.68 Cr | ₹6.37 Cr |
| Interest | ₹20 Cr | ₹9.32 Cr | ₹4.06 Cr | ₹6.60 Cr | ₹7.37 Cr |
| Depreciation | ₹17 Cr | ₹21 Cr | ₹17 Cr | ₹13 Cr | ₹13 Cr |
| Profit Before Tax | ₹32 Cr | ₹40 Cr | ₹54 Cr | ₹50 Cr | ₹41 Cr |
| Profit After Tax | ₹21 Cr | ₹28 Cr | ₹39 Cr | ₹35 Cr | ₹31 Cr |
| Consolidated Net Profit | ₹19 Cr | ₹27 Cr | ₹39 Cr | ₹34 Cr | ₹29 Cr |
| Earnings Per Share (Rs) | ₹22.20 | ₹31.30 | ₹46.22 | ₹40.47 | ₹34.29 |
| PAT Margin (%) | 6.94 | 10.46 | 16.67 | 16.16 | 16.92 |
| ROE(%) | 7.41 | 10.39 | 16.17 | 16.16 | 16.38 |
| ROCE(%) | 9.59 | 9.60 | 14.12 | 17.33 | 16.53 |
| Total Debt/Equity(x) | 0.82 | 0.96 | 0.86 | 0.46 | 0.60 |
Key Financials |
||
| Market Cap | : | ₹ 1,482.6 Cr |
| Revenue (TTM) | : | ₹ 311.1 Cr |
| Net Profit(TTM) | : | ₹ 24.7 Cr |
| EPS (TTM) | : | ₹ 29.1 |
| P/E (TTM) | : | 60.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HESTER BIOSCIENCES | 0.8% | 5.4% | -0.4% |
| SUN PHARMACEUTICAL INDUSTRIES | -7.3% | 1.1% | 15.2% |
| DIVIS LABORATORIES | -3.5% | 12.9% | 53.4% |
| CIPLA | 0.1% | 9.2% | 6.5% |
| TORRENT PHARMACEUTICALS | -1% | 0.2% | 19.9% |
| DR REDDYS LABORATORIES | 3.1% | 9.8% | -7.6% |
| MANKIND PHARMA | 5.5% | 5% | 8.8% |
| ZYDUS LIFESCIENCES | 0.5% | 5.6% | -10.5% |
| LUPIN | -0.4% | 6.1% | 26.5% |
HESTER BIOSCIENCES Revenues
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | 14.45 % |
| 5 Yr CAGR | 13.54 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹305 Cr | 14.45 | |
| Mar2023 | ₹266 Cr | 13.23 | |
| Mar2022 | ₹235 Cr | 9.65 | |
| Mar2021 | ₹214 Cr | 16.95 | |
| Mar2020 | ₹183 Cr | - | |
HESTER BIOSCIENCES Operating Profit
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | 5.48 % |
| 5 Yr CAGR | -1.03 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹53 Cr | 5.48 | |
| Mar2023 | ₹50 Cr | -15.97 | |
| Mar2022 | ₹60 Cr | -12.64 | |
| Mar2021 | ₹69 Cr | 23.93 | |
| Mar2020 | ₹55 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -7.81 % |
| 5 Yr CAGR | -12.82 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 17.46% | -7.81 | |
| Mar2023 | 18.94% | -25.78 | |
| Mar2022 | 25.52% | -20.32 | |
| Mar2021 | 32.03% | 5.95 | |
| Mar2020 | 30.23% | - | |
HESTER BIOSCIENCES Profit After Tax
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | -29.06 % |
| 5 Yr CAGR | -10.29 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹19 Cr | -29.06 | |
| Mar2023 | ₹27 Cr | -32.28 | |
| Mar2022 | ₹39 Cr | 14.20 | |
| Mar2021 | ₹34 Cr | 18.03 | |
| Mar2020 | ₹29 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -33.65 % |
| 5 Yr CAGR | -19.97 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 6.94 % | -33.65 | |
| Mar2023 | 10.46 % | -37.25 | |
| Mar2022 | 16.67 % | 3.16 | |
| Mar2021 | 16.16 % | -4.49 | |
| Mar2020 | 16.92 % | - | |
HESTER BIOSCIENCES Earnings Per Share (EPS)
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | -29.07 % |
| 5 Yr CAGR | -10.30 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹22 | -29.07 | |
| Mar2023 | ₹31 | -32.28 | |
| Mar2022 | ₹46 | 14.21 | |
| Mar2021 | ₹40 | 18.02 | |
| Mar2020 | ₹34 | - | |
HESTER BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | -0.10 % |
| 5 Yr CAGR | -12.73 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 9.59% | -0.10 | |
| Mar2023 | 9.6% | -32.01 | |
| Mar2022 | 14.12% | -18.52 | |
| Mar2021 | 17.33% | 4.84 | |
| Mar2020 | 16.53% | - | |
HESTER BIOSCIENCES Share Price vs Sensex
| Current Share Price | : | ₹1,744.2 |
| Current MarketCap | : | ₹ 1,482.6 Cr |
| Updated EOD on | : | May 12,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 0.8% |
5.4% |
-0.4% |
| SENSEX | 2% |
9.4% |
11.6% |
HESTER BIOSCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE SMALLCAP | 1.6% | 6.2% | 4.3% |
| BSE HEALTHCARE | -1.8% | 2.6% | 16.4% |
No NSE index found
You may also like the below Video Courses
FAQ about HESTER BIOSCIENCES Financials
How the annual revenues of HESTER BIOSCIENCES have changed ?
The Revenues of HESTER BIOSCIENCES have increased by 14.45% YoY .
How the Earnings per Share (EPS) of HESTER BIOSCIENCES have changed?
The Earnings Per Share (EPS) of HESTER BIOSCIENCES has decreased by -29.07 % YoY .
Check out Intrinsic Value of Peers of HESTER BIOSCIENCES
Compare Stock Analytics of Peers of HESTER BIOSCIENCES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
